Oruka Therapeutics, Inc.
ORKACIK 0000907654 · last filing Jul 1, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
3,558,410 bought / 3,558,410 sold
net +0 sh · −$300.45M
- buys
- 2
- sells
- 4
- insiders active
- 6
Filing tape
Filed Wed, Jul 1, 2026
- −0 sh · $300.01M
Fairmount Funds Management LLC +4 — Director · 10% owner
- Converted3,553,410Common Stock→ 4,685,364 held
- Sold3,553,410Common Stock@ $84.43→ 1,131,954 held
- Converted42,641Series B Preferred Stock→ 94,497 held
- −0 sh · $433.1K
Sandler Laura Lee — Chief Operating Officer
- Exercised5,000Common Stock@ $7.80→ 241,384 held
- Sold2,237Common Stock@ $93.85→ 239,147 held
- Sold2,263Common Stock@ $94.75→ 236,884 held
- Sold500Common Stock@ $95.47→ 236,384 held
- Exercised5,000Employee Warrant (right to buy)→ 79,996 held
Insiders on this tape
- Fairmount Funds Management LLCDirector · 10% owner
- Fairmount Healthcare Fund II L.P.Director · 10% owner
- Fairmount Healthcare Co-Invest III L.P.Director · 10% owner
- Kiselak TomasDirector · 10% owner
- Harwin Peter EvanDirector · 10% owner
- Sandler Laura LeeChief Operating Officer
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.